Sibilia J et al. – The results of three controlled studies using rituximab in RA demonstrated the efficacy of rituximab in patients with RA, including those who had been unresponsive or intolerant to one or more TNF inhibitor therapies. A longer follow-up duration and data from off-trial patients, included in registries, are now required.
See all
